万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>妇产科学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>病理学

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY《国际妇科病理学杂志》 (官网投稿)

简介
  • 期刊简称INT J GYNECOL PATHOL
  • 参考译名《国际妇科病理学杂志》
  • 核心类别 高质量科技期刊(T3), SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率7.50%
  • 主要研究方向医学-PATHOLOGY 病理学;OBSTETRICS & GYNECOLOGY 妇产科学

主要研究方向:

等待设置主要研究方向
医学-PATHOLOGY 病理学;OBSTETRICS & GYNECOLOGY 妇产科学

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY《国际妇科病理学杂志》(双月刊). International Journal of Gynecological Pathology is the official journal of the...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://journals.lww.com/intjgynpathology/pages/default.aspx

3、投稿网址:http://www.editorialmanager.com/ijgp/

4、官网邮箱:ellensol@mskcc.org(主编)

cooks@mskcc.org(总编)

5、官网电话:(212) 639-5696(总编)

6、期刊刊期:双月刊,逢单月出版。

2021716日星期五

                                 

 

投稿须知【官网信息】

 

Instructions for Authors

SCOPE

The International Journal of Gynecological Pathology is dedicated to advances in gynecological pathology, especially those that lead to improved patient care or to a better understanding of human gynecological disease. Primary emphasis will be placed on investigation of human disorders in the field of anatomic pathology. Articles devoted to experimental research or lower animal pathology will be considered if clearly related to an understanding of human disease. The journal itself may solicit the submission of review articles, progress reports, editorials, symposia, etc., and will be pleased to review submissions along these lines from its readers and the Society membership.

Ethical/Legal Considerations

A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent, following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.

Conflicts of interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

Copyright: In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).

A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.

Open access

Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.

The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.

Authors retain copyright

Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.

Creative Commons license

Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.

Compliance with funder mandated open access policies

An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php

FAQ for open access

http://www.wkopenhealth.com/openaccessfaq.php

Lora Hedrick Ellenson, M.D.

Attending Pathologist, Director of Gynecologic Pathology

Department of Pathology

Memorial Sloan Kettering Cancer Center

New York, NY 10056

ellensol@mskcc.org

Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.

Please go to the Journal website and click the ‘‘Permissions’’ link above the title of the paper in the abstract or html window for the relevant article. Alternatively send an email to customercare@copyright.com. Translation Rights & Licensing queries: Please contact, Silvia Serra, Translations Rights, Licensing & Permissions Manager, Wolters Kluwer Health (Medical Research) Ltd, 250 Waterloo Road, London SE1 8RD, UK. Phone +44 (0)207 981 0600; Silvia.Serra@wolterskluwer.com.

Manuscript Guidelines

On-line manuscript submission: All manuscripts must be submitted on-line through the new Web site at https://www.editorialmanager.com/ijgp/. First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Once you are registered please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Sarah Virgo, Managing Editor cooks@mskcc.org, (212) 639-5696, fax (212) 772-8521. Requests for help and other questions will be addressed in the order received.

Preparation of Manuscript

Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

Title page: Title page must be submitted as a separate file. Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) all sources of support, including pharmaceutical and industry support, that require acknowledgment.

The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).

Summary (Abstract): Abstract must be submitted as a separate file. Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (e.g., 'the significance of the results is discussed'). List three to five key words or phrases.

Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.

Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.

Case Reports: Case Reports must provide significant new information to be considered for publication. These are abbreviated manuscripts that occupy not more than 10 double-spaced type-written pages including tables, figures, and references. The number of references should be 15 or fewer and the number of figures should be 3 or fewer. Manuscripts intended as Case Reports should be labeled as such. Manuscripts intended as Case Reports that are accepted for publication but exceed the required length may be returned to the authors for appropriate revision. Please note that some Case Reports will be published online only.

Letters to the Editor: Letters to the Editor should pertain to articles published within the International Journal of Gynecological Pathology and highlight important new insights. Text should contain 500 words or fewer. Please note that some Letters to the Editor will be published online only.

References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data-such as papers submitted but not yet accepted for publication and personal communications, including e-mail communications-in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references, written in the AMA reference style, are given below:

Journal

1. Schneider PS, Krumholz BA, Topp WC, et al. Molecular heterogeneity of female genital wart (condylomata acuminata) papilloma viruses. Int J Gynecol Pathol 1984;2:329-36.

Book

2. Stenger SJ. Interpretation of Liver Biopsies. New York: Raven Press, 1984. (Blaustein A, ed. Biopsy interpretation series).

Chapter in book

3. Catchpole HR. Connective tissue, basement membrane, extracellular matrix. In: Ioachim HL, ed. Pathobiology Annual 1982. New York: Raven Press, 1982:1-33.

Software

4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.

Online journals

5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.

Database

6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.

World Wide Web

7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.

Figures & Artwork: For detailed information, including step-by-step instructions on creating new artwork or preparing existing artwork for publication, please refer to the Artwork Guidelines page on this site.

Art should be created/scanned and saved and submitted as either a TIFF, EPS, or PPT file.

Line art must have a resolution of at least 1200 dpi, and electronic photographs—radiographs, CT scans, and so on—and scanned images must have a resolution of at least 300 dpi.

If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files.

Color images must be created/scanned and saved and submitted as CMYK files.

Artwork generated from office suite programs such as CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) CANNOT be used.

Cite figures consecutively, and number them in the order in which they are discussed.

When submitting single-column width figures, the editor strongly recommends that these be oriented vertically to allow larger image size. The orientation of the figures in the electronic submission will be interpreted by the production staff as the desired orientation in the final publication. Therefore, authors should submit single-column figures oriented vertically if at all possible.

The publisher will charge $50 for each image file that must be repurposed from hard copy.

Figure Legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.

Color Figures: The journal accepts for publication color figures that will enhance an article. Beginning with the 2009 volume, there is no additional charge for color figures.

Tables: Create tables using the table creating and editing feature of your word processing software (e.g. Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file. Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.

Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.

Supplemental Digital Content

Supplemental Digital Content (SDC): Authors may submit SDC via Editorial Manager to LWW journals that enhance their article's text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.

SDC Call-outs

Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as "Supplemental Digital Content," include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.

Example:

We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.

List of Supplemental Digital Content

A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.

Example:

Supplemental Digital Content 1.wmv

SDC File Requirements

All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.

English Language Assistance for Authors: Appropriate use of the English language is a requirement for publication in The International Journal of Gynecological Pathology. Authors who have difficulty in writing in English may seek assistance with grammar and style to improve the clarity of their manuscript. Many companies provide substantive editing via the Web. Website addresses for these companies include:

www.themedicaleditor.com

www.biosciencewriters.com

www.bostonbioedit.com

www.sciencedocs.com

www.prof-editing.com

www.journalexperts.com

Please note that neither The International Journal of Gynecological Pathology nor The International Society of Gynecological Pathologists takes responsibility for, or endorses, these services. Their use does not guarantee acceptance of a manuscript for publication.

After Acceptance

Electronic page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and marking the electronic page proofs. Corresponding author must provide an email address. The proof/correction process is done electronically.

It is the author's responsibility to ensure that there are no errors in the proofs. Authors who are not native English speakers are strongly encouraged to have their manuscript carefully edited by a native English-speaking colleague. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Electronic proofs must be checked carefully and corrections returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.

Reprints: Authors will receive an email notification with a link to the order form soon after their article publishes in the journal (https://shop.lww.com/author-reprint). Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.558.6234; E-mail: authorreprints@wolterskluwer.com with any questions.


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭